Fund details
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35072 | 0.99% |
To provide long-term capital growth by investing primarily in equity securities of companies outside of North America. The fund provides exposure to economies that offer different business cycles and growth opportunities than North American markets.
Series |
Currency |
Fund code |
MER * (%) |
---|---|---|---|
F | CAD | 35072 | 0.99% |
Top 10 Holdings |
% Assets |
---|---|
Hitachi Ltd | 2.8% |
Mitsubishi Heavy Industries Ltd | 2.8% |
Novo Nordisk A/S - Class B Shares | 2.7% |
Sony Group Corp | 2.6% |
EssilorLuxottica SA | 2.4% |
Allianz SE | 2.4% |
ASML Holding NV | 2.3% |
Roche Holding AG | 2.2% |
Taiwan Semiconductor Manufacturing Co Ltd | 2.0% |
AstraZeneca PLC | 1.9% |
Total % of Top 10 Holdings | 24.1% |
1 Mth | 3 Mth | 6 Mth | 1 year | 3 years | 5 years | 10 years | Since Inception | |||
---|---|---|---|---|---|---|---|---|---|---|
4.3 | 0.6 | 5.5 | 6.9 | 12.1 | 9.1 | 6.9 | 4.8 | Fund |
YTD* | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Total distributions | 0.00 | 0.37 | 0.43 | 1.11 | 0.18 | 0.20 | 0.36 | 0.42 | 0.21 | 0.22 | 0.16 |
Interest | --- | 0.01 | 0.01 | 0.01 | 0.00 | 0.01 | 0.00 | 0.00 | --- | --- | --- |
Canadian dividends | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Foreign dividends | --- | 0.42 | 0.48 | 1.18 | 0.20 | 0.21 | 0.39 | 0.48 | 0.24 | 0.25 | 0.19 |
Foreign taxes paid | --- | -0.05 | -0.06 | -0.07 | -0.02 | -0.02 | -0.04 | -0.06 | -0.03 | -0.03 | -0.03 |
Capital gains | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
Return of capital | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
* MER (%) is based on actual expenses for the preceding calendar year or most recent half-year period ended June 30 expressed on an annualized basis, depending on availability of date at the time of publication.